Reliance Pharma Fund (G) |
|
|
|
|||||||||||||||||||||
|
|
|||||||||||||||||||||||
| Fund Type | Open-Ended |
| Scheme Objective | The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. |
| Launch Date | May 26, 2004 |
| Asset Size (Rs cr) | 573.43 (Dec-30-2011) |
| Minimum Investment | Rs.5000 |
| Entry Load | 0.00% |
| Exit Load | 1.00% |
| Load Comments | Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment. |
| Fund Manager | Sailesh Raj Bhan |
| Benchmark | BSE HEALTHCARE |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Response | |||
| From Date | NAV(Rs.) | To Date | NAV(Rs.) |
| 10-02-2011 | 51.022 | 10-02-2012 | 54.696 |
| Absolute Returns* 7.2% | |||
| Returns have been calculated after adjusting the NAVs for dividends, & bonus, if any. Click here to view Dividend History. | |||
| 52-week High 60.13 (Jul 14, 11) | 52-week Low 50.08 (Feb 28, 11) |
| Historic Graph | ||||||||
| From : | To : | |||||||
| Sector - Pharma & Healthcare | ||
| Funds in this category are not ranked |
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Tata Steel | Vodafone Essar | Mahindra Satyam | Commodities | Reliance Industries | BSE Sensex | Aurobindo Pharma | Vodafone | Montek Singh Ahluwalia 



